COMMUNIQUÉS West-GlobeNewswire

-
Orchestra BioMed Announces AVIM Therapy-Focused Satellite Symposium at HRS 2025 Annual Meeting
23/04/2025 -
Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery
23/04/2025 -
NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
23/04/2025 -
Shineco Announces Acquisition of Singapore Evolutionary Stem Cell Company
23/04/2025 -
Conavi Medical Corp. Announces Closing of $20M Public Offering
23/04/2025 -
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”
23/04/2025 -
Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference
23/04/2025 -
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
23/04/2025 -
Bluejay Therapeutics Announces Upcoming Presentation of Preclinical Data in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at European Association for the Study of the Liver (EASL) Congress 2025
23/04/2025 -
Enlivex Therapeutics to Showcase Allocetra’s Potential in Osteoarthritis at OARSI 2025 World Congress
23/04/2025 -
Vivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025
23/04/2025 -
Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites
23/04/2025 -
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection
23/04/2025 -
OneMedNet and Protege Partner to Advance the Future of AI-Driven Healthcare with Real-Time, Multimodal Data
23/04/2025 -
Hospice Choices: VITAS® Healthcare Expands in Austin, Texas
23/04/2025 -
VivoSim to Carry Forward Organovo 3D Bioprinting
23/04/2025 -
Rezolute Announces Pricing of Offering of $90 Million of Common Stock and Pre-Funded Warrants
23/04/2025 -
Phathom Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide Business Update on Thursday, May 1, 2025
23/04/2025 -
Arialief Reviews And Complaints (INVESTIGATIVE REPORT) Safe Ingredients for Neuropathy Relief or Over Hype?
23/04/2025
Pages